The Digestive Disease Week conference in San Diego unveiled compelling new analysis from a recent Phase 3 clinical trial. The findings suggest that a live biotherapeutic, primarily used to prevent the recurrence of Clostridioides difficile infection, may also enhance mental health parameters, creating a significant correlation with alterations in the gut's microbiome and metabolome. Patients…
Tackling Burnout among Infection Preventionists: A Call for Urgent Support and Sustainable Solutions
Burnout among infection preventionists (IPs), a critical issue exacerbated by the COVID-19 pandemic, calls for immediate attention and sustainable solutions. This article, based on a personal narrative, highlights the prevalence of burnout among IPs and the urgent need for systemic support. The author of this account, Sinéad Creedon, a part-time PhD student and a full-time…
In healthcare innovation, San Diego-based ARS Pharmaceuticals has developed a novel needle-free alternative for severe allergies –Neffy, an FDA-approved epinephrine nasal spray. Envisioned as an easy-to-use, child-friendly solution, this could bring marked changes to emergency allergy treatment.
In Anaheim, growing concerns over homeless encampments have reportedly led to stricter enforcement of city laws. The City Council's…